Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Civil Litigation topic
No spam. Unsubscribe anytime.
Senate adopts bill to standardize evidence for estimating unincurred medical damages
Summary
Senate Bill 833 passed after floor debate aiming to clarify how courts and juries may consider evidence about the reasonable value of future medical treatment when actual payments have not yet been made.
Get email alerts on the Civil Litigation topic
No spam. Unsubscribe anytime.
The Oklahoma Senate approved Senate Bill 833 on third reading after extended floor discussion about how best to value medical care that has not yet been provided.
Senator Patrick Daniels, sponsor of the bill, said the measure is intended to provide clarity and fairness when litigants and juries must estimate the reasonable value of future medical care and related expenses. The bill outlines categories of admissible evidence for establishing reasonable value, including provider bills, reimbursement rates, and standard-of-care estimates.
Senator Tanner Brooks pressed several questions about the effect of insurer-negotiated discounts, out-of-network charges and whether the approach could disadvantage certain injured parties. Brooks repeatedly asked whether the bill would result in lower awards for plaintiffs whose insurers paid low negotiated rates or for uninsured plaintiffs; Daniels and other proponents said the bill attempts to standardize calculations by permitting use of prevailing reimbursement rates (including Medicare rates where applicable) as a neutral benchmark when insurance payment data are not available.
Senator Hamilton asked for clarification about whether the proposed standards could undercompensate long-term needs for younger plaintiffs; the sponsor answered that the goal is to provide consistency while acknowledging the inherent uncertainty of estimating future treatment costs.
After floor debate, the roll call was 29 ayes and 18 nays; the bill was declared passed on final reading.
What it means: Courts will have a more prescribed set of evidentiary options when juries consider the reasonable value of future, unincurred medical treatment. Supporters say that standardization will reduce inconsistent results and clarify litigation; opponents warned it could compress recovery amounts for some injured plaintiffs depending on reimbursement assumptions.
Votes at passage: Senate Bill 833 โ passed 29โ18.
